One firm we’ve got lined a number of occasions right here is Mangoceuticals, Inc. (NASDAQ: MGRX), an up-and-coming Nasdaq small-cap launching disruptive services targeted on the quickly rising $31 billion males’s well being and wellness market.
The corporate’s co-founder and CEO, Jacob Cohen, was interviewed final week on the favored McNallie Cash YouTube podcast. It’s value trying out.
The interview phase does a superb job of offering an in-depth sense of the place this story is heading, and Mr. Cohen knocks it out of the park when it comes to capturing why MGRX is such an fascinating small-cap progress alternative.
You’ll be able to take a look at the complete video HERE.
The Interview
Bryce McNallie begins by exploring how MangoRx was born, and the way Mr. Cohen acquired concerned. It seems Cohen had been an investor in each healthcare and telemedicine, and he recognized telemedicine as a serious progress theme.
MangoRx was developed as a recent angle on telemedicine focusing on what Cohen noticed as a particularly promising however very underserved area of interest: males’s wellness merchandise developed for and marketed to a youthful male demographic.
To focus on that market, Cohen says recent messaging angles and humor have been key elements of the corporate’s technique on the advertising and marketing facet. That is exemplified by the corporate’s “Some issues are higher arduous” viral video, which has tens of millions of natural views, and its “Make American Arduous Once more” nationwide marketing campaign, which incorporates the pink hats and even a Trump impersonating avenue performer.
The interview ranges from there to exploring MangoRx’s ED merchandise.
Authentic Mango (assume: “Man, Go!”) provides a particular formulation that includes the identical energetic ingredient that powers Cialis™ (Tadalafil) together with different FDA authorized elements to maximise efficacy. These different elements are Oxytocin and L-Arginine—the previous is a compound often known as “the love hormone”, serving to to foster intimacy and heat, whereas the latter is an amino acid recognized to assist enhance blood circulation.
And it’s all packaged in a quickly dissolved orally absorbed pill able to producing ends in quarter-hour, with results lasting as much as 36 hours.
Nevertheless, just some weeks in the past, the corporate introduced the upcoming launch of its second Mango ED product leveraging its current customized compound alongside Sildenafil, which is the energetic ingredient present in Viagra™ delivered, like authentic Mango, in a quickly dissolving mango-flavored pill that prompts and dissolves orally for rapid motion.
The opposite fascinating edge the corporate has put in place, as famous above, is its distinctive telemedicine platform. Mango is a prescription treatment that should be authorized by a doctor. However the firm has arrange a telehealth infrastructure to assist in that course of: After a person has accomplished an internet telehealth go to, MGRX’s community of medical suppliers will evaluate and approve a prescription if medically applicable, after which ship the product instantly to the client.
Cohen goes on to debate the corporate’s recipe for achievement as being about its capability to realize an edge in three areas directly: Formulation, Advertising and marketing, and Packaging.
This results in a dialogue of the corporate’s current game-changing collaborations, together with the GaS Community, Barstool Sports activities, Solely Stans, Adam22, No Jumper. The corporate is discovering its place within the combine with a goal on non-traditional advert methods the place the secret is its concentrate on retailers with a robust and confirmed enchantment to a youthful male demographic.
Towards the top of the interview, Cohen lays out an thrilling imaginative and prescient for the long run that features new merchandise, new methods, new verticals—all focusing on its wheelhouse within the males’s well being and wellness house.
The interviewer, Bryce McNallie, makes level in closing that captures the essence of why this inventory is so fascinating: these people are specializing in serving to males dwell higher, more healthy, happier lives. That may be a essentially underserved area of interest, which is nice for its prospects, but additionally good for its buyers, because the competitors barrier is comparatively skinny regardless of focusing on a $31 billion market.
Once more, this interview piece is a terrific option to actually perceive the MGRX story and why this can be a robust small-cap Nasdaq alternative.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com
